Latest Breaking News On - Celcuity inc - Page 1 : comparemela.com

Celcuity To Participate in Jefferies Global Healthcare Conference

MINNEAPOLIS, June 03, 2024 Celcuity Inc. , a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced its participation in the Jefferies.

New yorkUnited statesVicky hahneBrian sullivanMaria yonkoskiCelcuity incGlobenewswire incGlobal healthcare conferenceChief executive officer

Celcuity (NASDAQ:CELC) Stock Price Up 8 1%

Celcuity (NASDAQ:CELC) Stock Price Up 8 1%
modernreaders.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from modernreaders.com Daily Mail and Mail on Sunday newspapers.

United statesCraig hallumStifel nicolausVanguard group incPoint incNeedham companyCelcuity company profileCelcuity incSg americas securitiesGet free reportFire capitalCelcuity daily

Celcuity Announces Pricing of Underwritten Common Stock Offering

Celcuity Announces Pricing of Underwritten Common Stock Offering
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesSan franciscoBrian sullivanMaria yonkoskiVicky hahneCelcuity incTd securities united statesNicolaus company incorporatedProspectus departmentGlobenewswire incLeerink partnersSyndicate departmentExchange commissionEventide asset managementCapital management

Celcuity Inc Announces Plan to Initiate a Phase 3 Clinical Trial for Gedatolisib as First-Line

Celcuity Inc Announces Plan to Initiate a Phase 3 Clinical Trial for Gedatolisib as First-Line
eagletribune.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from eagletribune.com Daily Mail and Mail on Sunday newspapers.

United statesSan diegoSan franciscoNew yorkAl iskandariyahBrian sullivanIgor gorbatchevskyVicky hahneMaria yonkoskiOxford financeCelcuity incExchange commission onInnovatus capital partnersDrug administrationArmentum partnersChief medical officer

Celcuity s (CELC) Buy Rating Reaffirmed at HC Wainwright

HC Wainwright reissued their buy rating on shares of Celcuity (NASDAQ:CELC – Free Report) in a report released on Thursday morning, Benzinga reports. They currently have a $27.00 price objective on the stock. HC Wainwright also issued estimates for Celcuity’s FY2028 earnings at $4.08 EPS. A number of other analysts also recently weighed in on […]

United statesCraig hallumStifel nicolausHealthcare of ontario pension plan trust fundPoint incSg americas securitiesNeedham companyCelcuity incFree reportStock downGet free reportFire capitalFinancial marketsOntario pension plan trust fundCelcuity daily